Περίληψη:
Objectives Neuropathic pain (NP) is a complex condition that impairs the
patients’ quality of life. Registries are useful tools, increasingly
used as they provide high-quality data. This article aims to describe
the Greek Neuropathic Pain Registry (Gr.NP.R.) design, the patients’
baseline data, and real-world treatment outcomes. Methods The Gr.NP.R.
collects electronically, stores, and shares real-world clinical data
from Pain and Palliative Care centers in Greece. It is a web-based
application, which ensures security, simplicity, and transparency. VAS,
DN4, and Pain Detect were used for pain and NP assessment. Results From
2016 to 2020, 5980 patients with chronic pain, of cancer or non-cancer
origin, were examined and 2334 fulfilled the NP inclusion criteria (VAS
> 5, DN4 > 4, and Pain Detect >= 19). At the first visit, the mean age
was 64.8 years, 65.5% were female patients, and 97.9% were Greek. The
mean (SD) time from pain initiation to visiting the pain clinics was 1.5
(3.8) years. Most patients were undertreated. Following the patients’
registration, the national guidelines were implemented. The majority of
the prescribed medications were gabapentinoids (70.2%), especially
pregabalin (62.6%), and opioids (tramadol, 55.3%). At visits 1 and 6,
mean VAS was 7.1 and 5, and mean DN4 score was 5.6 and 3.5,
respectively. Conclusions The Gr.NP.R. provides information on the
demographics, clinical progress, treatment history, treatment responses,
and the drugs of choice for patients with cancer and non-cancer NP. The
collected data may help physicians plan the management of their
patients.
Συγγραφείς:
Vadalouca, Athina
Alexopoulou-Vrachnou, Evnomia
Rekatsina,
Martina
Kouroukli, Irene
Anisoglou, Sousana
Kremastinou,
Fani
Gabopoulou, Zoi
Chloropoulou, Panagiota
Micha, Georgia
and Tsaroucha, Athanasia
Siafaka, Ioanna
